Ken Griffin Enfusion, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$7.89 - $9.69 $311,655 - $382,755	-39,500 Reduced 84.76%	7,100 $67,000
Q2 2024 Aug 14, 2024	BUY	$8.15 - $9.78 $57,865 - $69,438	7,100 Added 17.97%	46,600 $397,000
Q1 2024 May 15, 2024	BUY	$7.78 - $9.57 $122,924 - $151,206	15,800 Added 66.67%	39,500 $365,000
Q4 2023 Feb 14, 2024	BUY	$7.87 - $10.23 $81,061 - $105,369	10,300 Added 76.87%	23,700 $229,000
Q3 2023 Nov 14, 2023	SELL	$7.83 - $11.45 $166,779 - $243,884	-21,300 Reduced 61.38%	13,400 $120,000
Q2 2023 Aug 14, 2023	BUY	$7.54 - $11.22 $260,130 - $387,090	34,500 Added 17250.0%	34,700 $389,000
Q1 2023 May 15, 2023	BUY	$10.07 - $12.1 $1,007 - $1,210	100 Added 100.0%	200 $2,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $14.17 $872 - $1,417	100 New	100 $0

117

90.9M

45K

600

Ticker ENFN
Exchange NYSE
Sector Technology
Industry Software—Application
Shares Outstandng 67,001,700
Market Cap $709M
Description
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.